Substrate-enhancement therapy for mitochondrial metabolism modulation
A novel substrate-enhancement therapy using 4-hydroxybenzoic acid (4HB) to stimulate COQ2 enzyme activity, improving mitochondrial function in genetic disorders. This approach compensates for enzyme deficiencies, offerin...